Xin-Sheng Deng1, Xianzhong Meng2, QingChun Zeng2, David Fullerton2, Max Mitchell3, James Jaggers4. 1. Cardiothoracic Surgery, University of Colorado, Children's Hospital Colorado, Aurora, Colorado; Cardiothoracic Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 2. Cardiothoracic Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado. 3. Cardiothoracic Surgery, University of Colorado, Children's Hospital Colorado, Aurora, Colorado. 4. Cardiothoracic Surgery, University of Colorado, Children's Hospital Colorado, Aurora, Colorado; Cardiothoracic Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado. Electronic address: james.jaggers@childrenscolorado.org.
Abstract
BACKGROUND: Aortic valve interstitial cells (AVICs) have been implicated in the pathogenesis of calcific aortic valve disease. Signal transducer and activator of transcription 3 (Stat3) possesses antiinflammatory effects. Given that calcification occurs in adult valves, we hypothesized that AVICs from adult valves more likely undergo a proosteogenic phenotypic change than those from pediatric valves and that may be related to different Stat3 activation in the response of those two age groups to toll-like receptor 4 (TLR4). METHODS: AVICs from healthy human aortic valve tissues were treated with TLR4 agonist lipopolysaccharide. Cellular levels of TLR4, intercellular adhesion molecule 1, bone morphogenetic protein 2, and alkaline phosphatase, as well as phosphorylation of p-38 mitogen-activated protein kinase (MAPK), nuclear factor-κβ (NF-κβ), and Stat3, were analyzed. RESULTS: Toll-like receptor 4 protein levels were comparable between adult and pediatric AVICs. Adult cells produce markedly higher levels of the above markers after TLR4 stimulation, which is negatively associated with phosphorylation of Stat3. Inhibition of Stat3 enhanced p-38 MAPK and NF-κβ phosphorylation and exaggerated the expression of the above markers in pediatric AVICs after TLR4 stimulation. CONCLUSIONS: Adult AVICs exhibit greater inflammatory and osteogenic responses to TLR4 stimulation. The enhanced responses in adult AVICs are at least partly due to lower levels of Stat3 activation in response to TLR4 stimulation relative to pediatric cells. Stat3 functions as a negative regulator of the TLR4 responses in human AVICs. The results suggest that Stat3 activation (tyrosine phosphorylation) may be protective and that TLR4 inhibition could be targeted pharmacologically to treat calcific aortic valve disease.
BACKGROUND: Aortic valve interstitial cells (AVICs) have been implicated in the pathogenesis of calcific aortic valve disease. Signal transducer and activator of transcription 3 (Stat3) possesses antiinflammatory effects. Given that calcification occurs in adult valves, we hypothesized that AVICs from adult valves more likely undergo a proosteogenic phenotypic change than those from pediatric valves and that may be related to different Stat3 activation in the response of those two age groups to toll-like receptor 4 (TLR4). METHODS: AVICs from healthy human aortic valve tissues were treated with TLR4 agonist lipopolysaccharide. Cellular levels of TLR4, intercellular adhesion molecule 1, bone morphogenetic protein 2, and alkaline phosphatase, as well as phosphorylation of p-38 mitogen-activated protein kinase (MAPK), nuclear factor-κβ (NF-κβ), and Stat3, were analyzed. RESULTS:Toll-like receptor 4 protein levels were comparable between adult and pediatric AVICs. Adult cells produce markedly higher levels of the above markers after TLR4 stimulation, which is negatively associated with phosphorylation of Stat3. Inhibition of Stat3 enhanced p-38 MAPK and NF-κβ phosphorylation and exaggerated the expression of the above markers in pediatric AVICs after TLR4 stimulation. CONCLUSIONS: Adult AVICs exhibit greater inflammatory and osteogenic responses to TLR4 stimulation. The enhanced responses in adult AVICs are at least partly due to lower levels of Stat3 activation in response to TLR4 stimulation relative to pediatric cells. Stat3 functions as a negative regulator of the TLR4 responses in human AVICs. The results suggest that Stat3 activation (tyrosine phosphorylation) may be protective and that TLR4 inhibition could be targeted pharmacologically to treat calcific aortic valve disease.
Authors: Xin-Sheng Deng; Shuiliang Wang; Anlong Deng; Bolin Liu; Susan M Edgerton; Stuart E Lind; Reema Wahdan-Alaswad; Ann D Thor Journal: Cell Cycle Date: 2012-01-15 Impact factor: 4.534
Authors: Ashok N Babu; Xianzhong Meng; Ning Zou; Xiaoping Yang; Maorong Wang; Yong Song; Joseph C Cleveland; Michael Weyant; Anirban Banerjee; David A Fullerton Journal: Ann Thorac Surg Date: 2008-07 Impact factor: 4.330
Authors: Xianzhong Meng; Lihua Ao; Yong Song; Ashok Babu; Xiaoping Yang; Maorong Wang; Michael J Weyant; Charles A Dinarello; Joseph C Cleveland; David A Fullerton Journal: Am J Physiol Cell Physiol Date: 2007-10-17 Impact factor: 4.249
Authors: Juliane Wolf; Birgit Weinberger; Christoph R Arnold; Andrea B Maier; Rudi G J Westendorp; Beatrix Grubeck-Loebenstein Journal: Exp Gerontol Date: 2012-07-09 Impact factor: 4.032
Authors: Cassandra L Clift; Yan Ru Su; David Bichell; Heather C Jensen Smith; Jennifer R Bethard; Kim Norris-Caneda; Susana Comte-Walters; Lauren E Ball; M A Hollingsworth; Anand S Mehta; Richard R Drake; Peggi M Angel Journal: Sci Rep Date: 2021-05-07 Impact factor: 4.379
Authors: Carmen García-Rodríguez; Iván Parra-Izquierdo; Irene Castaños-Mollor; Javier López; J Alberto San Román; Mariano Sánchez Crespo Journal: Front Physiol Date: 2018-03-12 Impact factor: 4.566